MTR-16 MISMATCH REPAIR DEFECTS PREDICT CLINICAL OUTCOME OF PRIMARY AND RECURRENT MALIGNANT GLIOMAS

Benzer Materyaller

• PATH-45. DIFFERENT TYPES OF HYPERMUTATOR PHENOTYPE OF GLIOBLASTOMA ACCORDING TO MUTATION PATTERNS OF MISMATCH REPAIR GENES
  Yazar:: Saito, Kuniaki, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• GENE-61. TEMOZOLOMIDE-INDUCED MISMATCH REPAIR INSUFFICIENCY AND HYPERMETHYLATION OF MGMT PROMOTER WITH HYPERMUTATION IN MALIGNANT GLIOMAS
  Yazar:: Saito, Kuniaki, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status
  Yazar:: Tabei, Yusuke, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• PATH-08. CHALLENGES IN OPTIMIZATION OF MGMT PROMOTER METHYLATION ASSAYS FOR DEVELOPMENT OF COMPANION DIAGNOSIS IN GLIOBLASTOMA
  Yazar:: Nagane, Motoo, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• STMO-09 Recovery from speech deficit after injury to frontal aslant tract in glioma surgery
  Yazar:: Saito, Kuniaki, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)